Out of the 11 patients with concordant P/LPGVs in BRCA2, 3 had variants identified in ovarian cancer, 4 in breast cancer, and 1 each in brain, uterine, pancreatic, and upper GI malignancies. Here, BRCA2 is linked to ovarian cancer.